Lin Lab
The Lin Lab, led by Dr. Xihong Lin at the Harvard T.H. Chan School of Public Health, advances genomics and human disease research using innovative statistical and machine learning methods. Our team analyzes large-scale genetic, genomic, and health data to study complex diseases, focusing on areas like whole genome sequencing, functional variant annotation, polygenic risk prediction, and gene-environment interactions. We develop scalable tools, including FAVOR and STAAR, and prioritize improving prediction accuracy for underrepresented populations.
Consortia and Affiliates
The Lin Lab works with several consortia and affiliates to further our work in the field of genomics and biostatistics, including the following:
- TOPMed NHLBI Trans-Omics for Precision Medicine WGS-About TOPMed (nih.gov)
- GSP Genome Sequencing Program
- UKBiobank UK Biobank – UK Biobank
- AllofUS All of Us Research Program | National Institutes of Health (NIH)
- IGVF Impact of Genomic Variation on Function (IGVF) Consortium
- ILCCO International Lung Cancer Consortium